David M Spencer Net Worth & Insider Trades
David M Spencer - Chief Technology Officer, Bellicum Pharmaceuticals, Inc
What is David M Spencer's Net Worth?
The current estimated net worth of Bellicum Pharmaceuticals, Inc's Chief Technology Officer, David M Spencer, is estimated to be about $1.99M . David M Spencer owns about 99,939 units of Bellicum Pharmaceuticals, Inc common stock. In the last 4 years at Bellicum Pharmaceuticals, Inc, David M Spencer has sold an estimated value of $1.28M worth.
What is David M Spencer's Past Insider Trading?
David M Spencer's largest sale order was 16,500 units , worth over $328.02K on September 23, 2016. In total, David M Spencer has made about 16 transactions over 4 years of their time at Bellicum Pharmaceuticals, Inc. David M Spencer usually trades in December, with the busiest year in 2016. The most recent transaction was a sale order of 40,000 units , worth over $305.13K on July 20, 2018.
David Spencer
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is David M Spencer's' Mailing Address?
- Mailing address is C/o Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030 TX
Bellicum Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Richard A. Fair, | 2020 | $625,910 | - | $1,786,412 | $249,190 | $21,433 | $2,682,945 |
| Richard A. Fair, | 2019 | $566,204 | - | $1,021,004 | $127,990 | $17,690 | $1,732,888 |
| Atabak Mokari, | 2020 | $408,373 | $163,764 | $542,889 | - | $536,708 | $1,651,734 |
| Atabak Mokari, | 2019 | $375,000 | - | $669,168 | $61,500 | $2,233 | $1,107,901 |
| Shane M. Ward, | 2020 | $407,752 | $164,114 | $412,193 | - | $552,275 | $1,536,334 |
| Shane M. Ward, | 2019 | $374,062 | - | $153,151 | $61,705 | $17,941 | $606,859 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1358403/000119312521141608/d176237ddef14a.htm
What are Bellicum Pharmaceuticals, Inc's Past Insider Trades?
Bellicum Pharmaceuticals, Inc's most recent insider trade came on March 19, 2020 by Richard A Fair who bought 5,000 units worth $20K . In the last 5 years, insiders at Bellicum Pharmaceuticals, Inc have sold an estimated value of $18.67M and bought an estimated value of $2.85M worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are David Spencer, Chief Technology Officer, Kevin Slawin, Director, and Alan A Musso, CFO and Treasurer .
BELLICUM PHARMACEUTICALS, INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||